Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Merck & Co., Inc. (MRK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
86.12-0.52 (-0.60%)
At close: 04:04PM EDT
86.12 0.00 (0.00%)
After hours: 07:55PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close86.64
Open87.25
Bid81.32 x 800
Ask91.46 x 800
Day's Range86.10 - 87.61
52 Week Range71.50 - 95.72
Volume9,035,613
Avg. Volume8,173,601
Market Cap218.166B
Beta (5Y Monthly)0.34
PE Ratio (TTM)13.15
EPS (TTM)6.55
Earnings DateOct 27, 2022
Forward Dividend & Yield2.76 (3.20%)
Ex-Dividend DateSep 14, 2022
1y Target Est100.90
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
8% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MRK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Merck & Company, Inc.
    Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    13 days agoMorningstar
View more
Advertisement
Advertisement